Open AccessAngiopoietin-2 promotes extracellular matrix degradation in human degenerative nucleus pulposus cells
Author(s) -
Kun Wang,
Liang Kang,
Wei Liu,
Yu Song,
Xinghuo Wu,
Yukun Zhang,
Wenbin Hua,
Kangcheng Zhao,
Shuai Li,
Ji Tu,
Rongjin Luo,
Cao Yang
Publication year - 2018
Publication title -
international journal of molecular medicine
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.048
H-Index - 90
eISSN - 1791-244X
pISSN - 1107-3756
DOI - 10.3892/ijmm.2018.3576
Subject(s) - blot , angiopoietin , aggrecan , extracellular matrix , real time polymerase chain reaction , angiogenesis , intervertebral disc , immunohistochemistry , cell , microbiology and biotechnology , biology , chemistry , pathology , medicine , cancer research , gene , anatomy , biochemistry , vascular endothelial growth factor , alternative medicine , vegf receptors , osteoarthritis , articular cartilage
In contrast to healthy intervertebral discs (IVDs), degenerate IVDs become vascularized. Here, we determined the role of an angiogenesis promoter, angiopoietin (Ang)-2, in the pathology of IVD degeneration (IDD). We evaluated degree of IDD using the Pfirrmann grading system. We used quantitative real-time polymerase chain reaction and western blotting to analyze ANG2 gene expression and Ang-2 protein levels, respectively. The involvement of Ang-2 in IVD degradation and regulation of nuclear factor-κB (NF-κB) signaling was examined by immunohistochemistry, western blotting and immunofluorescence. As a result, 10 samples with grades II and III IDD were categorized as the mild IDD group; for comparison, another 10 specimens with grades IV and V constituted the severe IDD group. Ang-2 expression was significantly higher in severe IDD than in mild IDD. Exogenous Ang-2 administration led to increased production of catabolic proteinases and loss of aggrecan and collagen II in degenerative NP cell cultures, which was mediated by the NF-κB signaling pathway. Elevated Ang-2 levels also increased interleukin-1β expression in degenerative NP cells. We conclude that the release of Ang-2 aggravates NP cell degradation and plays an important role in IDD. Ang-2 may thus constitute a novel therapeutic target for the treatment of IVD.